Back
Acta Physiologica 2011; Volume 201, Supplement 682
The 90th Annual Meeting of The German Physiological Society
3/26/2011-3/29/2011
Regensburg, Germany
INTERLEUKIN-1 INTERFERES WITH SARCOPLASMIC CA2+ RELEASE THROUGH THE SKELETAL MUSCLE RYANODINE RECEPTOR: A NEW MECHANISM EXPLAINING MUSCLE FAILURE IN CRITICAL ILLNESS MYOPATHY
Abstract number: O99
Yi1 B., Edwards2 J.N., Weber1 C., Cully2 T.R., Lee2 A., Launikonis2 B.S., Polyak1 F., Liu1 I., v1 Wegner F., Volkers3 M., Most3 P., *Friedrich4,1,2 O.
Question:
Critical illness myopathy (CIM) is a very common form of sepsis-related organ failure of skeletal muscle associated with prolonged weakness. Cellular studies suggest impaired Ca2+ homeostasis but no firm cellular mechanism has yet been established.
Methodology:
Force/Ca2+ transients were recorded in skinned skeletal muscle fibres with a force transducer/confocal microscope upon SR Ca2+ release (caffeine or low Mg2+) under control conditions or after IL-1 incubation. SR leak was assessed in EGTA containing solutions and IL-1 action compared to tetracaine. IL-1-RyR1-interaction was assessed by co-IP and colocalization immunofluorescence microscopy. Membrane integrity after L-1-challenge in cultured fibres was monitored by propidium iodide.
Result:
Consistently, caffeine-induced force/Ca2+ transients were larger after incubation with IL-1 compared to controls. However, low Mg2+-induced transients were merely blocked by IL-1. IL-1 reduced SR Ca2+ leak by ~20 %. The reduction of SR leak was via RyR1: the effect of 25 ng/l IL-1 was similar to ~100 mM tetracaine. Co-IP showed IL-1-RyR1 binding that was confirmed in single cell immuno-colocalization. Prolonged IL-1 challenge of intact single muscle cells in culture induced a compromised membrane integrity and intracellular accumulation of IL-1.
Conclusion:
Our data show that IL-1 interacts with RyR1 in muscle and reduces SR Ca2+ leak. Although this should result in increased SR Ca2+ load for release, physiological Ca2+ release is impaired by IL-1's second action to stabilize the inhibitory Mg2+ binding site. Our study provides a novel and firm mechanism for muscle failure in septic patients that should inspire future clinical studies on drugs targeting IL-1.
To cite this abstract, please use the following information:
Acta Physiologica 2011; Volume 201, Supplement 682 :O99